These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17331541)

  • 1. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
    Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
    J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citicoline: pharmacological and clinical review, 2006 update.
    Secades JJ; Lorenzo JL
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of choline-containing phospholipids on brain cholinergic transporters in the rat.
    Tayebati SK; Tomassoni D; Di Stefano A; Sozio P; Cerasa LS; Amenta F
    J Neurol Sci; 2011 Mar; 302(1-2):49-57. PubMed ID: 21195433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
    Conant R; Schauss AG
    Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?
    Amenta F; Parnetti L; Gallai V; Wallin A
    Mech Ageing Dev; 2001 Nov; 122(16):2025-40. PubMed ID: 11589920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological treatment of vascular cognitive impairment].
    Bidzan L
    Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction.
    Amenta F; Tayebati SK
    Curr Med Chem; 2008; 15(5):488-98. PubMed ID: 18289004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000269. PubMed ID: 15846601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
    Traini E; Bramanti V; Amenta F
    Curr Alzheimer Res; 2013 Dec; 10(10):1070-9. PubMed ID: 24156263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
    Parnetti L; Amenta F; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
    Scapicchio PL
    Int J Neurosci; 2013 Jul; 123(7):444-9. PubMed ID: 23387341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citicoline, use in cognitive decline: vascular and degenerative.
    García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
    J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline-containing phospholipids: relevance to brain functional pathways.
    Tayebati SK; Amenta F
    Clin Chem Lab Med; 2013 Mar; 51(3):513-21. PubMed ID: 23314552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies.
    Amenta F; Di Tullio MA; Tomassoni D
    Clin Exp Hypertens; 2002; 24(7-8):697-713. PubMed ID: 12450245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of mild cognitive impairment: value of citicoline].
    Abad-Santos F; Novalbos-Reina J; Gallego-Sandín S; García AG
    Rev Neurol; 2002 Oct 1-15; 35(7):675-82. PubMed ID: 12389156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats.
    Tomassoni D; Avola R; Mignini F; Parnetti L; Amenta F
    Brain Res; 2006 Nov; 1120(1):183-90. PubMed ID: 16989788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.